Nov 3 (Reuters) - U.S.-German genetic testing specialist Qiagen reported a surge in third-quarter profit on Wednesday, boosted by higher demand for its coronavirus tests amid a rise in infections due to the fast-spreading Delta variant.

Net income rose to $0.57 per share from $0.07 per share, a year earlier. (Reporting by Mrinalika Roy in Bengaluru; Editing by Devika Syamnath)